Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.14, $0.07 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.16 billion versus the consensus estimate of $5.94 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $4.81-$4.91, versus the consensus of $4.68.

• sees revenue of $23-$23.5 billion (unchanged) vs consensus of $23.2 billion

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here
.